Evaluation of CXCL 10 and IL-10 in COVID-19 pneumonia

Okab, Hayder Fadhil; Salih, Manal Badi; Jarulla, Bassim Abdulhussein

doi:10.2478/pneum-2023-0043

Abstract

Background

Dysregulation the immune system is characteristic of the severe stages of COVID-19 disease; therefore, the study aimed to highlight the defective immune regulation patients with COVID-19 pneumonia without chronic diseases.

Methods

The study included 180 individuals, 60 as a control group, and 120 patients with COVID-19, including 67 males and 53 females, whose ages ranged from 27 to 70 years, at Imam Al-Hussein Teaching Hospital in Thi-Qar Province, South of Iraq. The CXCL 10 and IL-10 were evaluated by enzyme-linked immunosorbent assay (ELISA).

Results

The current study recorded that CXCL 10 was significantly increased < 0.001 in patients compared to controls, while the IL-10 was decreased significantly in patients, within disease severity the CXCL 10 increased with progress of disease, and IL-10 increased in sever patients, according to BMI the CXCL 10 decrease in obese patients than over and normal weight, while IL-10 increased in normal weight patients.

Conclusion

This study investigated the CXCL 10 was highly elevated in COVID-19 patients than control group, also noted the CXCL 10 increased with disease progress, therefor consider a good marker for poor outcome, furthermore the obese patients are more likely to have severe outcomes than others, so BMI is considered a risk factor for patients.

References

T. Marjot et al., “Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study,” J. Hepatol., vol. 74, no. 3, pp. 567–577, 2021, doi: 10.1016/j. jhep.2020.09.024.
Open DOI Search in Google Scholar Back to article
S. W. Mohammed, “The role of IL-6 in pathogensis of covid -19,” Univ. Thi-Qar J. Sci., vol. 10, no. 1, pp. 4–7, 2023, doi: 10.32792/utq/utjsci/v10i1.895.
Open DOI Search in Google Scholar Back to article
A. Zghair and C. Kasim, “Bacteriophage and nanotechnology in the management of COVID-19: A Review Article,” Univ. Thi-Qar J. Sci., vol. 9, no. 2, pp. 29–37, 2022, doi: 10.32792/utq/utjsci/v9i2.900.
Open DOI Search in Google Scholar Back to article
A. Tufa et al., “Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study,” Front. Immunol., vol. 13, no. 7, pp. 1–14, 2022, doi: 10.3389/fimmu.2022.964179.
Open DOI Search in Google Scholar Back to article
C. Storm and C. Storm, “Cytokine Storm,” N. Engl. J. Med., vol. 384, no. 16, p. e59, 2021, doi: 10.1056/nejmc2036236.
Open DOI Search in Google Scholar Back to article
Y. Wang and S. Perlman, “COVID-19: Inflammatory Profile,” Annu. Rev. Med., vol. 73, pp. 65–80, 2022, doi: 10.1146/annurev-med-042220-012417.
Open DOI Search in Google Scholar Back to article
M. Ghasemzadeh, J. Ahmadi, and E. Hosseini, “Plateletleukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?,” Thromb. Res., vol. 213, no. 3, pp. 179–194, 2022, doi: 10.1016/j.thromres.2022.03.022.
Open DOI Search in Google Scholar Back to article
D. Darif, I. Hammi, A. Kihel, I. El Idrissi Saik, F. Guessous, and K. Akarid, “The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?,” Microb. Pathog., vol. 153, no. 2, p. 104799, 2021, doi: 10.1016/j.micpath.2021.104799.
Open DOI Search in Google Scholar Back to article
M. Gudowska-Sawczuk and B. Mroczko, “What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?,” Int. J. Mol. Sci., vol. 23, no. 7, pp. 1–13, 2022, doi: 10.3390/ijms23073673.
Open DOI Search in Google Scholar Back to article
F. Coperchini, L. Chiovato, L. Croce, F. Magri, and M. Rotondi, “The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system,” Cytokine Growth Factor Rev., vol. 53, no. 5, pp. 25–32, 2020, doi: 10.1016/j.cytogfr.2020.05.003.
Open DOI Search in Google Scholar Back to article
N. Zhang, Y. Zhao, and X. Wang, “CXCL10 an important chemokine. pdf,” Eur. Rev. Med. Pharmacol. Sci., vol. 24, pp. 7497–7505, 2020.
Search in Google Scholar Back to article
J. E. Allen, “IL-4 and IL-13: Regulators and Effectors of Wound Repair,” Annu. Rev. Immunol., vol. 41, no. 2, pp. 229–254, 2023, doi: 10.1146/annurev-immunol-101921-041206.
Open DOI Search in Google Scholar Back to article
J. G. de O. Santos et al., “Impact of SARS-CoV-2 on saliva: TNF-α, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM,” J. Oral Biosci., vol. 64, no. 1, pp. 108–113, 2022, doi: 10.1016/j. job.2022.01.007.
Open DOI Search in Google Scholar Back to article
N. Karin and H. Razon, “Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity,” Cytokine, vol. 109, no. 1, pp. 24–28, 2018, doi: 10.1016/j. cyto.2018.02.012.
Open DOI Search in Google Scholar Back to article
M. Blot et al., “CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS,” Crit. Care, vol. 24, no. 1, pp. 1–15, 2020, doi: 10.1186/s13054-020-03328-0.
Open DOI Search in Google Scholar Back to article
F. Coperchini, L. Chiovato, G. Ricci, L. Croce, F. Magri, and M. Rotondi, “The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved,” Cytokine Growth Factor Rev., vol. 58, no. 12, pp. 82–91, 2021, doi: 10.1016/j.cytogfr.2020.12.005.
Open DOI Search in Google Scholar Back to article
M. Basheer, E. Saad, R. Hagai, and N. Assy, “Clinical predictors of mortality and critical illness in patients with covid-19 pneumonia,” Metabolites, vol. 11, no. 10, pp. 1–13, 2021, doi: 10.3390/metabo11100679.
Open DOI Search in Google Scholar Back to article
W. Luo, J. W. Zhang, W. Zhang, Y. L. Lin, and Q. Wang, “Circulating levels of IL-2, IL-4, TNF-α, IFN-γ, and C-reactive protein are not associated with severity of COVID-19 symptoms,” J. Med. Virol., vol. 93, no. 1, pp. 89–91, 2021, doi: 10.1002/jmv.26156.
Open DOI Search in Google Scholar Back to article
M. Gudowska-Sawczuk, J. Kudelski, and B. Mroczko, “The role of chemokine receptor cxcr3 and its ligands in renal cell carcinoma,” Int. J. Mol. Sci., vol. 21, no. 22, pp. 1–11, 2020, doi: 10.3390/ijms21228582.
Open DOI Search in Google Scholar Back to article
S. Kochumon et al., “Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance,” Ther. Adv. Endocrinol. Metab., vol. 11, pp. 1–11, 2020, doi: 10.1177/2042018820930902.
Open DOI Search in Google Scholar Back to article
A. Da Porto et al., “Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection,” Front. Med., vol. 9, pp. 1–8, 2022, doi: 10.3389/fmed.2022.988686.
Open DOI Search in Google Scholar Back to article
S. B. Sen Omit et al., “Identification of Comorbidities, Genomic Associations, and Molecular Mechanisms for COVID-19 Using Bioinformatics Approaches,” Biomed Res. Int., vol. 2023, no. 12, pp. 1–23, 2023, doi: 10.1155/2023/6996307.
Open DOI Search in Google Scholar Back to article
M. Blot et al., “The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome,” J. Transl. Med., vol. 18, no. 1, pp. 1–14, 2020, doi: 10.1186/s12967-020-02646-9.
Open DOI Search in Google Scholar Back to article
Y. Zhao et al., “Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease,” JCI Insight, vol. 5, no. 13, pp. 4–14, 2020, doi: 10.1172/jci.insight.139834.
Open DOI Search in Google Scholar Back to article
S. Qi et al., “Sex differences in the immune response to acute COVID-19 respiratory tract infection,” Biol. Sex Differ., vol. 12, no. 1, pp. 1–10, 2021, doi: 10.1186/s13293-021-00410-2.
Open DOI Search in Google Scholar Back to article
Q. Lu et al., “Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients,” Int. J. Clin. Pract., vol. 75, no. 9, pp. 1–8, 2021, doi: 10.1111/ijcp.14462.
Open DOI Search in Google Scholar Back to article
J. R. Nakkala, Z. Li, W. Ahmad, K. Wang, and C. Gao, “Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases,” Acta Biomater., vol. 123, pp. 1–30, 2021, doi: 10.1016/j.act-bio.2021.01.025.
Open DOI Search in Google Scholar Back to article
H. Kolb, “Obese visceral fat tissue inflammation: from protective to detrimental?,” BMC Med., vol. 20, no. 1, pp. 1–14, 2022, doi: 10.1186/s12916-022-02672-y.
Open DOI Search in Google Scholar Back to article
M. Rahmati and M. A. Moosavi, “Cytokine-Targeted Therapy in Severely ill COVID-19 Patients: Options and Cautions,” Eurasian J. Med. Oncol., vol. 4, no. 2, pp. 179–180, 2020, doi: 10.14744/ejmo.2020.72142.
Open DOI Search in Google Scholar Back to article
A.-H. Ahmed and M. B. Salih, “Effect of the COVID-19 vaccine on sex hormones and their relationship with IL-10,” Int. J. Health Sci. (Qassim)., vol. 6, no. 4, pp. 11853–11859, 2022, doi: 10.53730/ijhs.v6ns1.7905.
Open DOI Search in Google Scholar Back to article
Y. Chang, M. Bai, and Q. You, “Associations between Serum Interleukins (IL-1 β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis,” Biomed Res. Int., vol. 2022, no. 1, pp. 1–5, 2022, doi: 10.1155/2022/2755246.
Open DOI Search in Google Scholar Back to article
M. A. F. Queiroz et al., “Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome,” Front. Cell. Infect. Microbiol., vol. 12, no. 6, pp. 1–11, 2022, doi: 10.3389/fcimb.2022.922422.
Open DOI Search in Google Scholar Back to article
L. Sun et al., “New concepts of IL-10-induced lung fibrosis: Fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis,” Am. J. Physiol. - Lung Cell. Mol. Physiol., vol. 300, no. 3, pp. 341–353, 2011, doi: 10.1152/ajplung.00122.2010.
Open DOI Search in Google Scholar Back to article
A. Saeidi et al., “T-cell exhaustion in chronic infections: Reversing the state of exhaustion and reinvigorating optimal protective immune responses,” Front. Immunol., vol. 9, no. NOV, pp. 1–12, 2018, doi: 10.3389/fimmu.2018.02569.
Open DOI Search in Google Scholar Back to article
C. Dimeglio, F. Herin, G. Martin-Blondel, M. Miedougé, and J. Izopet, “Antibody titers and protection against a SARS-CoV-2 infection,” J. Infect., vol. 84, no. 2, pp. 248–288, 2022, doi: 10.1016/j.jinf.2021.09.013.
Open DOI Search in Google Scholar Back to article